Product Overview
Ozenoxacin (CAS: 245765-41-7) is a non-fluorinated quinolone antibiotic with the molecular formula C₂₁H₂₁N₃O₃ and molecular weight 363.4113. It acts as a potent inhibitor of DNA gyrase and topoisomerase IV, targeting Gram-positive bacteria like Staphylococcus aureus and Streptococcus pyogenes14. Primarily used for topical treatment of impetigo in patients aged ≥2 months, it is available in cream formulations for skin infections13.
✨ Key Advantages
✅ High Purity: ≥99% (HPLC/GC verified), ensuring compliance with pharmaceutical standards13.
✅ Broad-Spectrum Activity: Effective against MRSA and MSSA with MIC values ranging from 0.008–4 mg/L14.
✅ Stable Storage: Maintains stability at 2–8°C (protected from light)13.
🔬 Application Fields
Dermatology: First-line therapy for impetigo caused by S. aureus14.
Antibiotic Research: Study of resistance mechanisms in Gram-positive pathogens45.
Pharmaceutical Synthesis: Intermediate for novel antibacterial agents37.
📜 Quality Certifications
Produced in GMP-certified facilities adhering to USP/EP/BP standards13.
Quality verified via HPLC, NMR, and mass spectrometry35.
Complies with MSDS guidelines for safe handling and transport35.
📈 Market Insights
The global topical antibiotics market is projected to grow at CAGR 5.1%, reaching $7.2B by 2030, driven by rising skin infections and demand for localized treatments14. Ozenoxacin’s efficacy against resistant strains positions it as a critical therapeutic option45.
China
